Chronic Myelogenous Leukemia, BCR-ABL1 Positive in Remission
Also known as: Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB01254 | Dasatinib | 1 | Terminated | 1 |
DB00619 | Imatinib | 1 | Terminated | 1 |
DB04868 | Nilotinib | 1 | Terminated | 1 |
DB08877 | Ruxolitinib | 1 | Terminated | 1 |
DB00531 | Cyclophosphamide | 1 / 2 | Active Not Recruiting | 1 |
DB01073 | Fludarabine | 1 / 2 | Active Not Recruiting | 1 |
DB01042 | Melphalan | 1 / 2 | Active Not Recruiting | 1 |
DB00688 | Mycophenolate mofetil | 1 / 2 | Active Not Recruiting | 1 |
DB00877 | Sirolimus | 1 / 2 | Active Not Recruiting | 1 |
DB06616 | Bosutinib | 2 | Recruiting | 1 |
DB01254 | Dasatinib | 2 | Recruiting | 1 |
DB00619 | Imatinib | 2 | Recruiting | 1 |
DB04868 | Nilotinib | 2 | Recruiting | 1 |